Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Marker of the Cellular Captation of Glucose: the IRAP Protein (IRAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02941874
Recruitment Status : Recruiting
First Posted : October 21, 2016
Last Update Posted : April 17, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Grenoble

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2019
  Estimated Study Completion Date : December 31, 2019